Provided by Tiger Fintech (Singapore) Pte. Ltd.

Intellia Therapeutics

8.09
+0.51006.73%
Post-market: 8.110.0209+0.26%19:58 EDT
Volume:7.21M
Turnover:58.70M
Market Cap:837.99M
PE:-1.55
High:8.40
Open:7.79
Low:7.75
Close:7.58
Loading ...

Barclays Sticks to Their Buy Rating for Intellia Therapeutics (NTLA)

TIPRANKS
·
28 Feb

Intellia Therapeutics Inc (NTLA) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...

GuruFocus.com
·
28 Feb

U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp

Reuters
·
28 Feb

Q4 2024 Intellia Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

Intellia Therapeutics: Hold Rating Amid Long-Term Prospects and Strategic Restructuring

TIPRANKS
·
28 Feb

Intellia Therapeutics Inc : JP Morgan Cuts to Neutral From Overweight; Cuts Target Price to $13 From $45

THOMSON REUTERS
·
28 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Intellia Therapeutics (NTLA) and Cullinan Management (CGEM)

TIPRANKS
·
28 Feb

Intellia Therapeutics price target raised to $14 from $12 at Citi

TIPRANKS
·
28 Feb

Analysts Offer Insights on Healthcare Companies: Ironwood Pharma (IRWD) and Intellia Therapeutics (NTLA)

TIPRANKS
·
28 Feb

William Blair Reaffirms Their Buy Rating on Intellia Therapeutics (NTLA)

TIPRANKS
·
28 Feb

BUZZ-Intellia Therapeutics jumps on better-than-expected Q4 collaboration revenue

Reuters
·
28 Feb

Intellia Therapeutics Delivers a Q4 Beat

Motley Fool
·
27 Feb

Stock Track | Intellia Therapeutics Soars 8.06% Premarket on Upbeat Q4 Results, Strong Pipeline Progress

Stock Track
·
27 Feb

Intellia Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Intellia Therapeutics Q4 Net Loss Narrows; Shares Rise Pre-Bell

MT Newswires Live
·
27 Feb

Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
27 Feb

Intellia Therapeutics Q4 Net Income USD -128.898 Million

Reuters
·
27 Feb

Earnings Flash (NTLA) Intellia Therapeutics Posts Q4 Collaboration Revenue $12.9M, vs. FactSet Est of $8.6M

MT Newswires Live
·
27 Feb

Earnings Flash (NTLA) Intellia Therapeutics Posts Q4 Net Loss $-1.27 a Share, vs. FactSet Est of $-1.33 Loss

MT Newswires Live
·
27 Feb

Intellia Therapeutics Q4 2024 GAAP EPS $(1.27) Beats $(1.36) Estimate, Sales $12.87M Beat $8.53M Estimate

Benzinga
·
27 Feb